Advertisement

Topics

Fosun and KKR extend deadline for $1.2bn Gland Pharma deal

07:31 EDT 1 Aug 2017 | in-PharmaTechnologis

Shanghai Fosun Pharma and KKR have agreed to extended the termination date for the former's proposed $1.2bn (€1bn) takeover of Gland Pharma.

Original Article: Fosun and KKR extend deadline for $1.2bn Gland Pharma deal

NEXT ARTICLE

More From BioPortfolio on "Fosun and KKR extend deadline for $1.2bn Gland Pharma deal"

Quick Search
Advertisement